Carregant...
CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety
Chimeric antigen receptor-T (CAR-T) cell immunotherapy is a novel method that is genetically engineered to recruit T cells against malignant disease. Administration of CAR-T cells has led to progress in hematological malignancies, and it has been proposed for solid tumors like colorectal cancer (CRC...
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890323/ https://ncbi.nlm.nih.gov/pubmed/33613769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.50509 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|